Singapore-headquartered digital health and data analytics startup Holmusk has secured a $9.75-million pre-Series A funding from Heritas Venture Fund and other new and existing investors.
Having established offices in the US, UK and Malaysia, Holmusk will use the financing to expand its footprint in the US and Europe, it said in a statement.
The company informs predictive algorithms and provides actionable insights for personalized medicine by partnering with pharmaceutical companies and healthcare providers. Its offerings include the GlycoLeap and SuperLeap apps for diabetics.
The firm is also expanding its assets in the area of behavioural health after acquiring MindLinc, an electronic medical record system. It claims to currently hold one of the largest behavioural health databases in the world.
“The world is faced with unprecedented health challenges and we’re thrilled to play our part in addressing them,” said Nawal Roy, founder and CEO of Holmusk.